Intelligent Neurological Function Evaluation System
Legal Citation
Summary of the Inventive Concept
An integrated system for evaluating neurological function, combining a computing device, a specialized apparatus, and advanced technologies like AI, IoT, blockchain, and novel materials to provide personalized, accurate, and secure assessments.
Background and Problem Solved
The original patent provided a system for evaluating neurological function, but it had limitations in terms of data security, accuracy, and user experience. The new inventive concept addresses these limitations by integrating cutting-edge technologies to create a more comprehensive and effective system.
Detailed Description of the Inventive Concept
The system comprises a computing device with a touch screen, an apparatus configured to attach to the computing device, and advanced technologies such as AI, IoT, blockchain, and novel materials. The AI module utilizes machine learning algorithms to analyze user interactions with the touch screen and provide personalized cognitive and/or neuromotor assessments. The blockchain-based data storage system securely stores and manages user data and test results. The IoT-enabled sensor system tracks user movements and provides real-time feedback during the test. The novel material-based haptic feedback system provides tactile feedback to users during the test. The system also integrates a machine learning-based predictive analytics system that identifies patterns in user data and provides personalized recommendations for improving cognitive and/or neuromotor function.
Novelty and Inventive Step
The new claims introduce novel combinations of technologies that enhance the accuracy, security, and user experience of the original system. The integration of AI, IoT, blockchain, and novel materials provides a unique and non-obvious solution to the limitations of the original patent.
Alternative Embodiments and Variations
Alternative embodiments of the system could include varying the type of computing device, using different AI algorithms, or incorporating additional sensors or feedback mechanisms. The system could also be adapted for use in different environments, such as clinical settings or remote testing.
Potential Commercial Applications and Market
The Intelligent Neurological Function Evaluation System has significant commercial potential in the healthcare and medical industries, particularly in the areas of neurological disease diagnosis and treatment. The system's ability to provide accurate, personalized, and secure assessments makes it an attractive solution for clinicians, researchers, and patients.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61B5/7271 |
| A | A61 | A61B3/032 |
| A | A61 | A61B5/11 |
| A | A61 | A61B5/112 |
| A | A61 | A61B5/1124 |
| A | A61 | A61B5/1125 |
| A | A61 | A61B5/16 |
| A | A61 | A61B5/165 |
| A | A61 | A61B5/225 |
| A | A61 | A61B5/4023 |
| A | A61 | A61B5/4076 |
| A | A61 | A61B5/4082 |
| A | A61 | A61B5/4088 |
| A | A61 | A61B5/162 |
| A | A61 | A61B2560/04 |
| A | A61 | A61B2562/0219 |
| G | G06 | G06F2203/04809 |
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Medical diagnostic technologies, specifically neurological and cognitive function assessment systems, involving computing devices, touch screen interfaces, and performance testing apparatus
Person of Ordinary Skill (PHOSITA) Profile
A biomedical engineer or medical technology specialist with expertise in diagnostic systems, touch screen interfaces, sensor technologies, and human-computer interaction, holding at least a master's degree with 3-5 years of experience in medical device design
Obviousness Rationale
A PHOSITA would recognize that the PTD's integration of AI, IoT, and blockchain technologies represents predictable extensions of the source patent's neurological testing apparatus, applying known computational techniques to enhance diagnostic capabilities through standard technological augmentation strategies.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,349 |
|---|---|
| Title | Apparatus and related method to facilitate test via a computing device |
| Assignee(s) | THE CLEVELAND CLINIC FOUNDATION, BIOGEN MA INC. |